Login / Signup

In vivo antitumour activity of Britanin against gastric cancer through nuclear factor-κB-mediated immune response.

Keru ShiXinyue LiuGetao DuXiaoxia CaiYonghua Zhan
Published in: The Journal of pharmacy and pharmacology (2020)
Britanin may be a promising candidate for gastric cancer chemotherapy, and its anticancer effect likely depends on an NF-κB-mediated immune response.
Keyphrases
  • nuclear factor
  • immune response
  • toll like receptor
  • dendritic cells
  • signaling pathway
  • inflammatory response
  • oxidative stress
  • lps induced
  • squamous cell carcinoma
  • cell proliferation